[1] 江秋维,黄理,姚朝光.乙型肝炎肝硬化并发食管胃底静脉曲张破裂出血患者临床特征及其危险因素分析.实用肝脏病杂志,2021,24(4):532-535. [2] Wu L, Fang QQ, Huang XQ,et al.Risk factors associated with failure of endoscopic combined treatment to prevent varices rebleeding in patients with liver cirrhosis. Expert Rev Gastroenterol Hepatol, 2023, 17(1/6):301-308. [3] Chi Q , Lv Z , Song W .Effect of a combination of omeprazole and high-dose proton pump inhibitors on the treatment of patients with liver cirrhosis complicated with upper gastrointestinal hemorrhage.Trop J Pharm Res, 2021, 20(10):2143-2148. [4] 杨熹,宋冬梅,华敏.生长抑素联合奥曲肽治疗肝硬化并发EVB患者疗效及其对凝血功能指标的影响再观察.实用肝脏病杂志,2020,23(5):695-698. [5] 中华医学会肝病学分会,中华医学会消化病学分会,中华医学会内镜学分会.肝硬化门静脉高压食管胃静脉曲张出血的防治指南.实用肝脏病杂志,2016,19(5):I0001-I0016. [6] 高慧茹,高会斌,彭昭,等.乙型肝炎肝硬化并发EVB患者临床特征及影响因素分析.实用肝脏病杂志,2021,24(3):395-398. [7] 白雪莉,杨连粤.肝硬化门静脉高压症食管,胃底静脉曲张破裂出血诊治专家共识(2019年版).中华消化外科杂志,2019(12):1087-1093. [8] Rivory J, Pioche M, Dumortier J,et al.Transesophageal endoscopic ultrasound-guided coil and cyanoacrylate treatment of challenging esophageal varices bleeding associated with CREST syndrome ulcerative esophagitis.Endoscopy, 2022, 54(12):E761-E762. [9] An Y, Bai Z, Xu X,et al.No benefit of hemostatic drugs on acute upper gastrointestinal bleeding in cirrhosis. Biomed Res Int, 2020, 2020(5):1-11. [10] Zheng S, Xue C, Li S,et al.Liver cirrhosis: current status and treatment options using western or traditional Chinese medicine. Front Pharmacol, 2024, 15(6):1381476. [11] Mao G, Li C, Wang H,et al.Exploration on the effect of nonselective β-receptor blockers (nsbbs) on hemodynamic parameters in complicated liver cirrhosis. Biomed Res Int, 2022, 2022(8):7922906. [12] Loganathan P, Lao A, Singh S,et al.Efficacy and safety of somatostatin analogue in chronic bleeding from gastrointestinal angiodysplasia: a systematic review and meta-analysis. Am J Gastroenterol, 2024, 119(10S):S718-S719. [13] Hao J, Zhang P, Fan L,et al.Efficacy of combined use of octreotide and sodium tanshinone IIA sulfonate in patients with cirrhosis complicated with severe acute pancreatitis. Trop J Pharm Res, 2024, 23(9):1491-1493. [14] Ismail B, Charnigo R, Ali SM, et al.Impact of octreotide on sodium level in cirrhotic inpatients with hyponatremia: a retrospective study. Eur J Gastroenterol Hepatol, 2023, 35(12):1394-1401. [15] Zou X, Liu L, Tan F, et al.Non-contrast-enhanced MR angiography of left gastric vein in patients with gastroesophageal varices: morphology and blood supply analysis. Eur Radiol, 2024, 34(7):4686-4696. [16] Redondo-Cerezo E, Ortega-Suazo EJ, Vadillo-Calles F, et al.Upper gastrointestinal bleeding in patients 80 years old and over. A comparison with younger patients and risk factors analysis for in-hospital and delayed mortality. Int J Clin Pract, 2021, 75(11):e14806. [17] He X, Dai Z, Shi P,et al. Intravenous drip of somatostatin followed by restricted fluid resuscitation to treat upper gastrointestinal bleeding in patients with liver cirrhosis. Evid Based Complement Alternat Med, 2021, 21(10):6548479. [18] Liu X, Guo X, Zhou H. Octreotide acetate combined with somatostatin upregulates miR-1291 and downregulates miR-331-3p in patients with cirrhosis and upper gastrointestinal bleeding. Am J Transl Res, 2021, 13(8):9883-9891. [19] Duan Y, Chen J, Cui H, et al. The effect of pantoprazole and somatostatin combined with thrombin in the treatment of non-esophagogastric varicosity upper gastrointestinal bleeding. Am J Transl Res, 2021, 13(5):5484-5490. [20] Zhang H, Chen L, Wang X, et al. Analysis of risk factors for hypoglycemia in patients with gastrointestinal bleeding induced by somatostatin for injection and establishment of the prediction model. Int J Clin Pharmacol Ther, 2024, 62(1):29-36. |